Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1992 | 12-1991 | 12-1990 | 12-1989 | 12-1988 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 3,152 | 1,901 | 1,219 | 617 | 909 |
| TOTAL | $3,152 | $1,901 | $1,219 | $617 | $909 |
| Non-Current Assets | |||||
| PPE Net | 5,566 | 4,872 | 5,355 | 5,653 | 4,870 |
| Other Non-Current Assets | 129 | 100 | 83 | 113 | 98 |
| TOTAL | $5,695 | $4,972 | $5,438 | $5,766 | $4,968 |
| Total Assets | $8,847 | $6,873 | $6,657 | $6,383 | $5,877 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 588 | 706 | 706 | 0 |
| Accounts payable and accrued liabilities | 5,088 | 5,096 | 2,289 | 3,625 | 3,021 |
| Other current liabilities | 0 | 431 | 431 | 163 | 0 |
| TOTAL | $5,088 | $6,115 | $3,426 | $4,494 | $3,727 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 2,000 |
| TOTAL | $276 | $346 | $625 | $500 | $2,430 |
| Total Liabilities | $5,364 | $6,461 | $4,051 | $4,994 | $6,157 |
| Shareholders' Equity | |||||
| Common Shares | 2,208 | 2,181 | 2,156 | 2,121 | 119 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -6 |
| TOTAL | $141,196 | $121,606 | $107,938 | $77,799 | $61,313 |
| Total Liabilities And Equity | $146,560 | $128,067 | $111,989 | $82,793 | $67,470 |